Wednesday, November 11, 2026||
MultiKhabarMultiKhabar

FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning

Share:WhatsAppFacebookX (Twitter)Telegram
FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

These drugs may be associated with a drop in blood flow to the optic nerve which can cause sudden, painless loss of vision in one eye, and sometimes the damage is permanent, FDA said

Key Takeaways

  • FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning.

These drugs may be associated with a drop in blood flow to the optic nerve which can cause sudden, painless loss of vision in one eye, and sometimes the damage is permanent, FDA said

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play